Avidity Biosciences - Stock Price History | RNA

Historical daily share price chart and data for Avidity Biosciences since 2022 adjusted for splits. The latest closing stock price for Avidity Biosciences as of May 23, 2022 is 13.24.
  • The all-time high Avidity Biosciences stock closing price was 35.94 on September 14, 2020.
  • The Avidity Biosciences 52-week high stock price is 29.59, which is 123.5% above the current share price.
  • The Avidity Biosciences 52-week low stock price is 11.02, which is 16.8% below the current share price.
  • The average Avidity Biosciences stock price for the last 52 weeks is 20.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Avidity Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 23.3271 25.4700 29.2600 18.1600 23.7700 -6.86%
2020 29.0006 31.4000 35.9400 23.3500 25.5200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.644B $0.009B
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00